Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
Recruiting
N/A
Interventional Study
Pancreas Cyst
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 120
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 800 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with pancreatic cystic lesions meeting Fukuoka worrisome or Fukuoka high-risk criteris
* Patients with suspected cystic neoplasm of the pancreas
* Able to provide written informed consent
Exclusion Criteria:
* Pregnant and/or nursing
* Incarceration
* Imaging showin…
Contacts